Category Archives: Uncategorized

Less than a month after the FDA refused to review Alkermes’ new drug application for the company’s depression drug, the

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: AGRI-SIMPLE-2018Pillar: AGRIP-1-1Opening Date: Deadline: Thu, 12 Apr 2018 17:00:00 (Brussels local time)Modification Date: Mon, 16 Apr 2018Latest

Last year Jerry Feitelson was accepted into BIO’s Start-up Stadium at the annual BIO International Convention. Armed with his six-minute

Microbial therapies developer Commense has appointed Edward “Tad” Stewart to serve as the Boston company’s president and CEO. Stewart was

Cellect Biotechnology (NASDAQ:APOP) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research

Kelly Martin has been named permanent CEO of Novan (NASDAQ: NOVN). The Morrisville, NC-based drug developer appointed Martin interim CEO

[Source: Research & Innovation] AFLoNext, a five-year collaborative project involving 40 entities from 15 countries, aimed at proving and maturing

Genetic engineering has long been a favorite topic for Hollywood screenwriters to exploit to make box office hits. From Jurassic

Louis Renzetti has been appointed chief scientific officer of New York-based Bridge Medicines. Renzetti most recently worked as chief research

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-MSCA-COFUND-2018Pillar: Excellent ScienceOpening Date: Deadline: Thu, 27 Sep 2018 17:00:00 (Brussels local time)Modification Date: Thu, 12 Apr